Concert Pharma (CNCE) Posts Q4 Loss of 36c/Share
Tweet
Share
E-mailGet Alerts CNCE Hot Sheet
Join SI Premium – FREE
Concert Pharma (NASDAQ: CNCE) reported Q4 EPS of ($0.36), $0.24 better than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Concert Pharma (CNCE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
- POET Technologies Inc. (POET) Misses Q2 EPS by 3c
- LENSAR, Inc. (LNSR) Tops Q2 EPS by 31c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
